The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07162792

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Xuzhou Third People's Hospital (from the registry)
Registry
  • NCT NCT07162792
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07162792. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-23 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT
Condition
de Novo Coronary Lesions
Intervention (Device)
bioresorbable scaffold
Intervention (Device)
drug-coated balloon
Lead sponsor
Xuzhou Third People's Hospital (class: other)

Record details

Record id
cardio:ct-nct07162792
Content hash
2618669a14b1135408bb1075febed95c5e0a8c7c0d12225d9c3e521bebb20dfc